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dverse Effects of Dopamine on
ystemic Hemodynamic Status and Oxygen
ransport in Neonates After the Norwood Procedure
ia Li, MD, PHD, Gencheng Zhang, MD, PHD, Helen Holtby, MBBS, Tilman Humpl, MD,
hristopher A. Caldarone, MD, Glen S. Van Arsdell, MD, Andrew N. Redington, MD
oronto, Ontario, Canada
OBJECTIVES The purpose of this study was to evaluate the effects of dopamine on hemodynamic status and
oxygen transport in neonates after the Norwood procedure.
BACKGROUND Dopamine is widely used to augment cardiac performance and increase oxygen delivery (DO2)
in patients after cardiopulmonary bypass (CPB). This might be at the expense of increased
myocardial and systemic oxygen consumption (VO2), thus offsetting the improved DO2. This
balance is particularly fragile in critically ill neonates.
METHODS Systemic oxygen consumption was continuously measured with respiratory mass spectrometry
in 13 sedated, paralyzed, and mechanically ventilated neonates for 72 h after the Norwood
procedure. Arterial, superior vena caval, and pulmonary venous blood gases were measured to
calculate pulmonary blood flow (Q p) and systemic blood flow (Q s), DO2, and oxygen
extraction ratio (ERO2). Rate-pressure product was calculated. Dopamine at a dose of 5
g/kg/min was routinely administered at cessation of CPB and terminated within the first
48 h. Hemodynamic and oxygen transport measures were obtained before and at 100 min
after the termination of dopamine.
RESULTS Terminating dopamine was not associated with significant changes in arterial pressure, Q p,
Q s, or DO2 but was associated with a significant decrease in heart rate (p  0.003),
rate-pressure product (p  0.03), and VO2 (20  11%, p  0.0001), resulting in a
significant decrease in ERO2 (p  0.01).
CONCLUSIONS Dopamine induces a significant increase in VO2 in neonates after the Norwood procedure,
and termination is associated with an improved balance of VO2–DO2. These data further
emphasize the importance of understanding changes in VO2 as well as DO2 in infants after
cardiac surgery. (J Am Coll Cardiol 2006;48:1859–64) © 2006 by the American College
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.038of Cardiology Foundation
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Vopamine, a precursor in the endogenous synthesis of
orepinephrine, is widely used to augment cardiac perfor-
ance and increase oxygen delivery (DO2) to tissues in
ritically ill patients with low cardiac output state (1–3),
ncluding those after cardiopulmonary bypass surgery (CPB)
4–7). It is well known that catecholamines might increase
yocardial oxygen consumption; however, they might also
ncrease systemic oxygen consumption (VO2). This occurs in
ways: first, by kindling cell metabolism via adrenergic
eceptors; and second, by their action on the central nervous
ystem and endogenous sympathetic drive (8–12). None-
heless, if the increase in DO2 is greater relative to VO2,
opamine might improve the overall balance of oxygen
ransport and tissue oxygenation, and some have reported
avorable responses to dopamine treatment in adults and
lder children after cardiac surgery (4–7). In neonates,
owever, unlike in the adult or older child, little or no
nformation is available about the effects of dopamine on
From the Cardiac Program, the Hospital for Sick Children, Toronto, Ontario,
anada. This work was supported by the Canadian Institute of Health Research (Drs.
i, Redington, and Van Arsdell).p
Manuscript received March 31, 2006; revised manuscript received June 26, 2006,
ccepted July 10, 2006.O2–DO2 relationship. This is of particular relevance in
eonates undergoing CPB to repair complex congenital
eart defects, such as the Norwood procedure, because of
heir limited myocardial functional reserve and the signifi-
antly elevated VO2 secondary to the systemic inflammatory
esponse to CPB (13). Furthermore, neonates have abun-
ant brown adipose tissue that is richly populated by
-adrenergic receptors, via which catecholamines can stim-
late thermogenesis and a substantial increase in VO2 (14).
ndeed, experimentally, dobutamine increased body temper-
ture, VO2, and oxygen extraction ratio (ERO2) in neonatal
ambs, an effect abrogated by adrenergic blockade (15). The
elevance of this study to neonates undergoing cardiac
urgery is less clear, however. Dobutamine is used relatively
arely in this population, and the adverse effect on ERO2 was
nly observed at relatively high doses. Furthermore, al-
hough the effects on thermogenesis and body temperature
ere important observations, body temperature is tightly
ontrolled in postoperative children, because of its known
elationship with VO2 (16,17). Thus, in the present study we
xamined the effect of dopamine on the balance between
O2 and DO2 in euthermic neonates during the early
ostoperative period after the Norwood procedure.
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atients. This study was approved by the Research Ethics
oard at the Hospital for Sick Children, Toronto, Canada.
ritten informed consent was obtained from the parents of
3 neonates (12 boys, age ranged from 4 to 16 days, median
) undergoing a Norwood procedure between April 2004
nd January 2006. The clinical characteristics of the patients
re shown in Table 1.
ntraoperative procedures. All patients were intubated
ith cuffed endotracheal tubes (Microcuff-Heidelberg-
ediatric; Microcuff GmbH, Weinheim, Germany). Gen-
ral anesthesia was maintained with inhaled isoflurane,
ntravenous fentanyl, and pancuronium bromide. A stan-
ard Norwood procedure with low-flow CPB and selective
erebral perfusion was employed (18). The aortic arch was
econstructed with a homograft patch. The 3.5-mm right
odified Blalock-Taussig shunt was completed with anas-
omosis of the distal conduit to the central pulmonary
rtery. All patients received methylprednisolone (30 mg/kg)
n the operating room at or before CPB. Phenoxybenzamine
.25 mg/kg was given at initiation of CPB. A bolus of
protinin 50,000 KIU/kg was given, followed by 100,000
IU/100 ml prime. Our protocol was to administer milri-
one (100 g/kg) before termination of CPB and to initiate
opamine (5 g/kg/min) at the time of cessation of bypass.
Abbreviations and Acronyms
BT-PVR  pulmonary vascular resistance inclusive of the
Blalock-Taussig shunt
CO  total cardiac output
CPB  cardiopulmonary bypass
DO2  systemic oxygen delivery
ERO2  oxygen extraction ratio
Q p  pulmonary blood flow
Q s  systemic blood flow
SVR  systemic vascular resistance
VO2  systemic oxygen consumption
able 1. Clinical Data for the 13 Patients
Patient
Age
(Days)
Weight
(kg)
BSA
(m2)
CPB
(Min)
ACC
(Min)
1 9 3.6 0.24 109 50
2 7 3.5 0.23 108 47
3 4 3.7 0.25 151 100
4 7 4.2 0.27 122 62
5 12 3.5 0.23 165 75
6 6 3.5 0.23 172 82
7 16 3.9 0.25 170 60
8 7 4 0.25 167 64
9 6 2.9 0.2 142 62
10 5 4.5 0.28 103 75
11 7 2.8 0.19 66 59
12 7 3.6 0.24 156 86
13 4 4.2 0.27 127 99
A aortic atresia; ACC aortic cross clamp; AS aortic stenosis; CPB cardiopu
LHS  hypoplastic left heart syndrome; LV  left ventricle; MA  mitral atresia; MS 
ransposition of great arteries; VSDs  multiple ventricular septal defects.odified ultrafiltration was performed in all patients. A
ulmonary venous line was inserted into the orifice of the
ight upper pulmonary vein. A direct oximetric sampling
atheter was inserted in the superior vena cava.
ostoperative management. Our protocol for manage-
ent was as follows: the central temperature (esophageal)
as maintained between 36° and 37°C. Postoperative mon-
toring included arterial, superior vena caval, and pulmonary
enous pressures; heart rate; and end-tidal carbon dioxide.
edation consisted of continuous intravenous infusion of
orphine and intermittent injections of a muscle relaxant
pancuronium) and lorazepam as required. Patients received
ime cycled pressure control/pressure support ventilation.
entilation volume and rate were adjusted to control partial
ressure of arterial carbon dioxide. Arterial oxygen satura-
ion was maintained between 70% and 85%. Hemoglobin
as maintained between 14 and 16 mg/dl. Vasoactive drugs
milrinone, phenoxybenzamine, and vasopressin) and vol-
me infusions (5% albumin or blood) were administered
ccording to our standard protocol (19). Dopamine was
ubsequently discontinued when the hemodynamic status
nd ventricular function were deemed satisfactory and
estarted according to clinical judgment.
ethods of measurements. PATIENT MONITORING. All
atients had continuous invasive monitoring of systemic,
uperior vena caval, and pulmonary venous pressures. Heart
ate was continuously monitored, as was the central body
emperature (esophageal).
XYGEN CONSUMPTION. Systemic oxygen consumption
as measured continuously with an AMIS2000 mass spec-
rometer (Innovision A/S, Odense, Denmark). This is a
ensitive and accurate method for continuous gas analysis
hat allows simultaneous measurements of multiple gas
ractions (20).
ALCULATIONS OF HEMODYNAMIC STATUS AND OXYGEN
RANSPORT. Blood samples were taken from the arterial,
uperior vena cava, and pulmonary vein lines for the
Circulatory
Arrest (Min)
Cerebral
Perfusion (Min) Diagnosis
4 44 HLHS, AS, MS
12 35 HLHS, AS, MS
35 53 HLHS, AS, MS
3 60 HLHS, AS, MS
13 59 DILV, TGA
9 70 HLHS, AA, MA
1 60 HLHS, AS, MS
17 44 HLHS, AS, MS
1 62 HLHS, AS, MS
45 30 DILV, TGA
17 20 HLHS, AA, MA
0 0 Criss-cross heart, VSDs
44 49 HLHS, AA, MA, TAPVC
ry bypass; DILV double inlet left ventricle; DORV double outlet right ventricle;lmona
mitral stenosis; TAPVC  total abnormal pulmonary venous connection; TGA 
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November 7, 2006:1859–64 Dopamine and O2 Transport in Postop Neonateseasurements of blood gases and oxygen saturation. Pul-
onary blood flow (Q p) and systemic blood flow (Q s) were
hen calculated with the direct Fick method. Total cardiac
utput (CO), DO2, systemic vascular resistance (SVR),
ulmonary vascular resistance inclusive of the Blalock-
aussig shunt (BT-PVR), and ERO2 were calculated with
tandard equations. Stroke volume was calculated as cardiac
utput divided by heart rate. The rate-pressure product was
alculated by multiplying the heart rate by the systolic
rterial blood pressure, an indirect index of myocardial VO2
21) (Table 2).
tudy protocol. Patients were studied during the first 72 h
fter arrival in the cardiac intensive care unit. Measurements
f VO2 were recorded continuously. However, for the
urpose of analysis, averaged recordings were made during a
0-min period just before and a 30-min period at 100 min
fter the termination of dopamine. Measurements of other
ystemic hemodynamic data and oxygen transport were also
btained within the periods. Patients were excluded if any
hanges in other treatments were made during the study
eriod.
ata analysis. Data are expressed as mean values  SD.
he data, collected before and after termination of dopa-
ine, were analyzed by paired t test. A p value  0.05 was
onsidered statistically significant.
ESULTS
opamine was administered at the cessation of CPB at 5
g/kg/min in 12 patients and 7.5 g/kg/min in the remain-
ng 1 (Patient 4) and subsequently terminated within the
rst 48 h in all patients. Table 3 and Figure 1 show the
hanges in systemic hemodynamic condition and oxygen
ransport at termination of dopamine. During the study
eriod, temperature was unchanged (p  0.05). Termina-
ion of dopamine of 5 g/kg/min (7.5 g/kg/min in Patient
) was associated with a significant reduction in heart rate
y a mean of 12  12 beats/min (p  0.003) but not with
able 2. Equations Using Oxygen Consumption (VO2) to
alculate Hemodynamics and Oxygen Transport Parameters
Parameters Equations
p (l/min/m
2) VO2/(CpvO2  CaO2)
s (l/min/m
2) VO2/(CaO2  CvO2)
O (l/min/m2) Q s  Q p
troke volume (ml/beat) CO/heart rate  1,000
VR (Wood unit  m2) (MAP  MVP)/Q s
T-PVR (Wood unit  m2) (MAP  MPVP)/Q p
O2 (ml/min/m
2) Q s  CaO2
RO2 VO2/DO2
ate-pressure product (unit) Heart rate  SAP
T-PVR  total pulmonary vascular resistance including Blalock-Taussig shunt;
aO2, CpvO2, CvO2  arterial (equal to pulmonary arterial), pulmonary venous, and
uperior vena caval oxygen contents, respectively; CO  total cardiac output; DO2 
ystemic oxygen delivery; ERO2  oxygen extraction ratio; MAP, MVP, and
PVP  arterial, superior vena caval, and pulmonary venous mean pressures,
espectively; Q p pulmonary blood flow; Q s systemic blood flow; SAP systolic
rterial pressure; SVR  systemic vascular resistance; VO2  systemic oxygen
onsumption.rterial blood pressure (p  0.05), resulting in a significant
Vecrease in rate-pressure product (p 0.03). There were no
ignificant changes in PVR-BT and Q p, SVR and Q s,
p/Q s, CO, stroke volume, and DO2 (p  0.05 for all).
he VO2 uniformly decreased in all patients from 105  23
l/min/m2 to 84  23 ml/min/m2 (p  0.0001), repre-
enting a 20  11% decrease. Figure 2 shows the examples
f on-line measurement of VO2 around the time of termi-
ating dopamine in 3 individual patients representing a
mall (A, Patient 3), moderate (B, Patient 2), and great (C,
atient 4) reduction of VO2. The drop in VO2 is clearly
emonstrated immediately after the termination of dopa-
ine. In the patient (Patient 4) who was given dopamine of
.5 g/kg/min, VO2 decreased by 39% (from 84 to 50
l/min/m2), the greatest among the patients (Fig. 2C). The
ecrease in VO2 resulted in a significant decrease in ERO2
rom 0.35  0.10 to 0.28  0.08, (p  0.01). There was no
orrelation between the age, body weight, or body surface
rea and the decrease in VO2 (R
2  0.10 to 0.14, p  0.05
or all). Arterial lactate also decreased significantly (p 
.05).
ISCUSSION
his study shows that in neonates after the Norwood
rocedure, dopamine has adverse effects on the balance of
O2 and DO2. Early termination of dopamine was associ-
ted with a significant decrease in VO2 leading to an
mproved VO2-DO2 balance reflected by a significant de-
rease in ERO2. It is likely that these counterintuitive effects
f dopamine largely reflect the stimulation of non-cardiac
issue metabolism.
Dopamine was first synthesized one century ago (22) and
as been widely used for 40 years (1–7) to augment cardiac
erformance in different forms of low cardiac output state.
opamine has differential agonist effects on the 3 main
able 3. Systemic Hemodynamic Condition and Oxygen
ransport Before and After Termination of Dopamine in
3 Neonates During the Early Period After the Norwood
rocedure
Time at Termination of
Dopamine Before After p Value
entral temperature (°C) 36.6  0.8 36.4  0.4 NS
ean arterial pressure (mm Hg) 45  5 46  7 NS
eart rate (beats/min) 162  13 150  8 0.003
ate-pressure product (U) 10,709 9,510 0.03
VR-BT (Wood unit  m2) 17.1  5.7 16.5  5.2 NS
VR (Wood unit  m2) 20.8  5.9 21.7  8.4 NS
p (l/min/m
2) 2.3  0.8 2.4  0.8 NS
s (l/min/m
2) 1.9  0.6 1.8  0.6 NS
p/Q s 1.2  0.4 1.4  0.4 NS
O (l/min/m2) 4.3  1.3 4.2  1.3 NS
troke volume (ml/beat) 27  9 28  10 NS
O2 (ml/min/m
2) 302  98 314  106 NS
O2 (ml/min/m
2) 105  23 84  23 0.0001
RO2 0.35  0.10 0.28  0.08 0.01
actate (mmol/l) 2.5  1.3 2.0  0.6 0.05alues are expressed as mean  SD.
Abbreviations as in Table 2.
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Dopamine and O2 Transport in Postop Neonates November 7, 2006:1859–64ypes of adrenergic receptors that are dose dependent. At
ow doses (3 g/min/kg), the effect of stimulation of
opaminergic receptors predominates, inducing a direct
rteriolar vasodilation to increase renal blood flow and an
ndirect increase in cardiac output. At moderate doses (4
g/min/kg), beta-adrenergic receptor stimulation (mainly
1 and 2) produces inotropic effects to increase stroke
olume and cardiac output. Higher doses (8 g/min/kg)
re now rarely used because of vasoconstriction provoked by
lpha-adrenergic receptor stimulation (23).
Although exerting inotropic effects, adrenergic receptor
timulation also increases metabolic rate, manifest as an
ncrease in VO2. This phenomenon was described 75 years
go, in studies of epinephrine in normal adults (24).
ubsequent studies in animals have shown that the effects of
atecholamines on cellular metabolism and thermogenesis
re mediated by 1, 2, and particularly 3-adrenergic
eceptor stimulation (9); might be potentiated by alpha-
drenergic receptor agonist (10,11); and might possibly
nvolve dopaminergic receptor stimulation (12). All of these
eceptors are densely expressed in brown adipocytes located
n brown adipose tissue. Brown adipose tissue is abundant in
uman neonates (14). Activation of brown adipocytes by
atecholamines, particularly by norepinephrine, plays a cru-
ial role in non-shivering thermogenesis, by means of
timulating fatty acid oxidation and uncoupling the respi-
atory chain from adenosine triphosphate (ATP) synthesis
igure 1. The individual (thin line) and mean (bold line with closed squ
nd after termination of dopamine in 13 neonates during the early period
RO2  oxygen extraction ratio; VO2  oxygen consumption.o produce a large amount of heat through uncoupling srotein 1 (9,14). Experimentally, dopamine, as a precursor
n the endogenous synthesis of norepinephrine, seems to
ave similar potency to norepinephrine in terms of increased
etabolic and VO2 responses (25,26). Thus, both circulatory
nd metabolic stimulating effects by catecholamines share
he same adrenergic signaling mechanisms. If the circulatory
esponses to adrenergic stimulation are reduced, or the
etabolic responses enhanced, the beneficial effects of
atecholamine stimulation might be abrogated.
Such is the case in patients, particularly neonates, after
PB. Systemic oxygen delivery is often low during the first
4 h, owing to myocardial injury resulting directly from
urgery and indirectly from ischemia-reperfusion injury and
he systemic inflammatory response (13,17,27). Further-
ore, neonatal hearts are known to have limited reserve to
ncrease cardiac contractility. The reserve might become
arginal in a Norwood circulation with the injured single
ight ventricle providing parallel pulmonary and systemic
irculations (13). In these patients, efforts to improve DO2
y catecholamines might be more likely to be associated
ith predominately adverse effects. This was the case in our
tudies. Dopamine exerted a primarily chronotropic rather
han inotropic effect, as indicated by the significant decrease
n heart rate (p  0.003) but insignificant change in stroke
olume (p  0.05) after termination of dopamine. Overall,
he use of dopamine did not increase DO2 and seemed to
ause an increase in myocardial VO2, as indicated by the
changes in systemic hemodynamic condition and oxygen transport before
the Norwood procedure. CO  cardiac output; DO2  oxygen delivery;ares)ignificantly higher rate-pressure product (p  0.03).
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November 7, 2006:1859–64 Dopamine and O2 Transport in Postop NeonatesWhereas DO2 is depressed, VO2 is increased during the early
ours after CPB, owing mainly to systemic inflammatory
esponse and repayment of oxygen debt accumulated from
PB (17,28), thus further burdening myocardial function. We
ave recently demonstrated that increased VO2 is the major
ontributor to the impairment of oxygen transport in neonates
uring the first 24 h after the Norwood procedure (13), and
ny treatment that might further increase VO2 is clearly
ndesirable. There is experimental evidence (15) that neonates
ight be particularly susceptible to the metabolic effects of
atecholamines. Penny et al. (15) showed that dobutamine, a
erivative of dopamine, increased DO2 similarly in 3 age groups
f lambs, but the increase in VO2 was 7- to 12-fold greater in
ewborns (1 to 2 days) as compared with the older groups (7
o 10 days and 6 to 8 weeks, respectively) and at higher doses
as associated with an increase in ERO2. This study demon-
trated a significant thermogenic effect of dobutamine, there
eing a significant rise in central temperature. In children after
pen heart surgery, central hyperthermia is associated with
ncreased VO2 (16). Indeed, we have previously shown an
igure 2. Examples of the on-line measurement of oxygen consumption
VO2) in 3 patients shows the rapid and small (A, Patient 3), moderate (B,
atient 2), and great (C, Patient 4) decreases in VO2 after terminating
opamine at different times after the arrival in the intensive care unit
ICU). Arrows indicate the time of terminating dopamine. Short bold
ines indicate the 30-min periods for averaging VO2 measures before and
00 min after terminating dopamine.pproximately 11% increase in VO2 for every 1°C rise in
aemperature above 36°C (16). For this reason, euthermia
hould be vigorously maintained in postoperative children.
his makes previous experimental observations regarding the
hermogenic and calorigenic effects of catecholamines difficult
o translate to clinical relevance. Nonetheless, in our human
eonatal studies, termination of dopamine of 5 g/min/kg was
ssociated with a substantial decrease in VO2 by approximately
0%. Consequently, given the insignificant change in DO2,
RO2 improved; while possibly a surrogate phenomenon, the
oncomitant fall in arterial lactate levels also suggests improved
ystemic metabolic efficiency.
tudy limitations. We could only measure global VO2 and
herefore were unable to dissect the myocardial and systemic
lements of the VO2 responses. Furthermore, because dif-
erent organs have different distribution of adrenergic re-
eptor subtypes, regional VO2–DO2 mismatch might be
on-uniform with dopamine treatment. Future studies
hould analyze the potential differential effects on the heart
29,30), splanchnic organs (31), and the brain (32). How-
ver, such an assessment of regional effects would likely
equire direct instrumentation of the target organ, which is
mpractical in a clinical study.
We were unable to examine a “dose response” effect of
opamine dosage, again because our protocol was constrained
y clinical practice. Nonetheless, our predominant dose of 5
g/kg/min reflects the commonest dose used in clinical prac-
ice, and adverse effects at this dose were clear. Finally, we are
nable to comment on the effects of dopamine, beneficial or
etrimental, when given at other times during postoperative
ourse. However, it is reasonable to conclude that outside of
he immediate 48 postoperative hours, the effects of dopamine
ight be adverse in this patient group. Indeed, it is now our
ractice to stop dopamine as early as possible after the return to
he cardiac intensive care unit.
Finally, we studied a discrete anatomic subset of neonates
ndergoing the Norwood procedure. Although this avoids
he confounding issues of multiple diseases and operative
trategies, our data cannot be extrapolated to all neonates
ndergoing cardiac surgery. Nonetheless, it seems unlikely
hat the responses are entirely specific.
onclusions. In neonates during the early postoperative
eriod after the Norwood procedure, a moderate dose of
opamine induces a predominant increase in VO2, adversely
ffecting the VO2–DO2 relationship. Termination of dopa-
ine is associated with an improved VO2–DO2 balance and
educed lactate production. Thus, dopamine should be used
ith caution in neonates after CPB. These data further
mphasize the importance of understanding changes in VO2
s well as DO2 in infants after cardiac surgery.
eprint requests and correspondence: Dr. Andrew N. Reding-
on, Division of Cardiology, The Hospital for Sick Children, 555
niversity Avenue, Toronto, Ontario, Canada M5G 1X8. E-mail:
ndrew.redington@sickkids.ca.
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